Normal aging is accompanied by cognitive deficiencies, affecting women and men equally. Aging is the main risk factor for Alzheimer’s disease (AD), with women having a higher risk. The higher prevalence of AD in women is associated with the abrupt hormonal decline seen after menopause. However, other factors may be involved in this sex-related cognitive decline. Alterations in gut microbiota (GM) and its bioproducts have been reported in AD subjects and transgenic (Tg) mice, having a direct impact on brain amyloid-β pathology in male (M), but not in female (F) mice.
Objective:
The aim of this work was to determine GM composition and cognitive dysfunction in M and F wildtype (WT) and Tg mice, in a sex/genotype segregation design.
Methods:
Anxiety, short term working-memory, spatial learning, and long-term spatial memory were evaluated in 6-month-old WT and Tg male mice. Fecal short chain fatty acids were determined by chromatography, and DNA sequencing and bioinformatic analyses were used to determine GM differences.
Results:
We observed sex-dependent differences in cognitive skills in WT mice, favoring F mice. However, the cognitive advantage of females was lost in Tg mice. GM composition showed few sex-related differences in WT mice. Contrary, Tg-M mice presented a more severe dysbiosis than Tg-F mice. A decreased abundance of Ruminococcaceae was associated with cognitive deficits in Tg-F mice, while butyrate levels were positively associated with better working- and object recognition-memory in WT-F mice.
Conclusion:
This report describes a sex-dependent association between GM alterations and cognitive impairment in a mice model of AD.
ScheyerO, RahmanA, HristovH, BerkowitzC, IsaacsonRS, Diaz BrintonR, MosconiL (2018) Female sex and Alzheimer’s risk: The menopause connection. J Prev Alzheimers Dis5, 225–230.
4.
Alzheimer Association (2019) Alzheimer’s disease facts and figures. Alzheimers Assoc15, 321–387.
5.
GilsanzP, LeeC, CorradaMM, KawasCH, QuesenberryCP, WhitmerRA (2019) Reproductive period and risk of dementia in a diverse cohort of health care members. Neurology92, e2005–e2014.
6.
FoxM, BerzuiniC, KnappLA (2013) Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer’s risk in a cohort of British women. Psychoneuroendocrinology38, 2973–2982.
7.
YamadaM, LandesRD, MimoriY, NaganoY, SasakiH (2015) Trajectories of cognitive function in dementia-free subjects: Radiation Effects Research Foundation Adult Health Study. J Neurol Sci351, 115–119.
8.
EalsM, SilvermanI (1994) The hunter-gatherer theory of spatial sex differences: Proximate factors mediating the female advantage in recall of object arrays. Ethol Sociobiol15, 95–105.
9.
McBurneyDH, GaulinSJC, DevineniT, AdamsC (1997) Superior spatial memory of women: Stronger evidence for the gathering hypothesis. Evol Hum Behav18, 165–174.
10.
GaleaLAM, KimuraD (1993) Sex differences in route-learning. Pers Individ Dif14, 53–65.
11.
HarshmanRA, HampsonE, BerenbaumSA (1983) Individual differences in cognitive abilities and brain organization, part I: Sex and handedness differences in ability. Can J Psychol37, 144–192.
12.
PetersA, JosephsonK, VincentSL (1991) Effects of aging on the neuroglial cells and pericytes within area 17 of the rhesus monkey cerebral cortex. Anat Rec229, 384–398.
13.
VoyerD, VoyerS, BrydenMP (1995) Magnitude of sex differences in spatial abilities: A meta-analysis and consideration of critical variables. Psychol Bull117, 250–270.
14.
ParsonsTD, RizzoAR, Van Der ZaagC, McGeeJS, BuckwalterJG (2005) Gender differences and cognition among older adults. Aging Neuropsychol Cogn12, 78–88.
15.
SavageRM, GouvierWD (1992) Rey auditory-verbal learning test: The effects of age and gender, and norms for delayed recall and story recognition trials. Arch Clin Neuropsychol7, 407–414.
16.
LawsK, IrvineK, GaleT (2016) Sex differences in cognitive impairment in Alzheimer’s disease. World J Psychiatry6, 54–65.
17.
WiederholtWC, CahnD, ButtersNM, SalmonDP, Kritz-SilversteinD, Barrett-ConnorE (1993) Effects of age, gender and education on selected neuropsychological tests in an elderly community cohort. J Am Geriatr Soc41, 639–647.
18.
MaylorEA, ReimersS, ChoiJ, CollaerML, PetersM, SilvermanI (2007) Gender and sexual orientation differences in cognition across adulthood: Age is kinder to women than to men regardless of sexual orientation. Arch Sex Behav36, 235–249.
19.
ReadS, PedersenNL, GatzM, BergS, VuoksimaaE, MalmbergB, JohanssonB, McClearnGE (2006) Sex differences after all those years? Heritability of cognitive abilities in old age. J Gerontol B Psychol Sci Soc Sci61, P137–P143.
20.
Proust-LimaC, AmievaH, LetenneurL, OrgogozoJ-M, Jacqmin-GaddaH, DartiguesJF (2008) Gender and education impact on brain aging: A general cognitive factor approach. Psychol Aging23, 608–620.
21.
GerstorfD, HerlitzA, SmithJ (2006) Stability of sex differences in cognition in advanced old age: The role of education and attrition. J Gerontol B Psychol Sci Soc Sci61, P245–P249.
SundermannEE, BiegonA, RubinLH, LiptonRB, MowreyW, LandauS, MakiPM; Alzheimer’s Disease Neuroimaging Initiative (2016) Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy. Neurology86, 1368–1376.
24.
SundermannEE, BiegonA, RubinLH, LiptonRB, LandauS, MakiPM; Alzheimer’s Disease Neuroimaging Initiative (2017) Does the female advantage in verbal memory contribute to underestimating Alzheimer’s disease pathology in women versus men?J Alzheimers Dis56, 947–957.
25.
ChapmanRM, MapstoneM, GardnerMN, SandovalTC, McCraryJW, GuillilyMD, ReillyLA, DeGrushE (2011) Women have farther to fall: Gender differences between normal elderly and Alzheimer’s disease in verbal memory engender better detection of Alzheimer’s disease in women. J Int Neuropsychol Soc17, 654–662.
26.
BeinhoffU, TumaniH, BrettschneiderJ, BittnerD, RiepeMW (2008) Gender-specificities in Alzheimer’s disease and mild cognitive impairment. J Neurol255, 117–122.
27.
BuckwalterJG, RizzoAA, McClearyR, ShankleR, DickM, HendersonVW (1996) Gender comparisons of cognitive performances among vascular dementia, Alzheimer disease, and older adults without dementia. Arch Neurol53, 436–439.
28.
HeunR, KocklerM (2002) Gender differences in the cognitive impairment in Alzheimer’s disease. Arch Womens Ment Health4, 129–137.
29.
BarnesLL, WilsonRS, BieniasJL, SchneiderJA, EvansDA, BennettDA (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry62, 685–691.
30.
SandbergG, StewartW, SmialekJ, TroncosoJC (2001) The prevalence of the neuropathological lesions of Alzheimer’s disease is independent of race and gender. Neurobiol Aging22, 169–175.
WangJ, TanilaH, PuoliväliJ, KadishI, van GroenT (2003) Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice. Neurobiol Dis14, 318–327.
33.
JiaoSS, Bu LeX, LiuYH, ZhuC, WangQH, ShenLL, LiuCH, WangYR, YaoXQ, WangYJ (2016) Sex dimorphism profile of Alzheimer’s disease-type pathologies in an APP/PS1 mouse model. Neurotox Res29, 256–266.
34.
ClintonLK, BillingsLM, GreenKN, CaccamoA, NgoJ, OddoS, McGaughJL, LaFerlaFM (2007) Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol Dis28, 76–82.
35.
JiangC, LiG, HuangP, LiuZ, ZhaoB (2017) The gut microbiota and Alzheimer’s disease. J Alzheimers Dis58, 1–15.
36.
LyteM, CryanJF (2014) Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease. Springer.
37.
RevelesKR, PatelS, ForneyL, RossCN (2019) Age-related changes in the marmoset gut microbiome. Am J Primatol81, e22960.
38.
LeeSM, KimN, ParkJH, NamRH, YoonK, LeeDH (2018) comparative analysis of ileal and cecal microbiota in aged rats. J Cancer Prev23, 70–76.
39.
BiagiE, NylundL, CandelaM, OstanR, BucciL, PiniE, NikkïlaJ, MontiD, SatokariR, FranceschiC, BrigidiP, De VosW (2010) Through ageing, and beyond: Gut microbiota and inflammatory status in seniors and centenarians. PLoS One5, e10667.
ZhuangZQ, ShenLL, LiWW, FuX, ZengF, GuiL, LüY, CaiM, ZhuC, TanYL, ZhengP, LiHY, ZhuJ, ZhouHD, BuXL, WangYJ (2018) Gut microbiota is altered in patients with Alzheimer’s disease. J Alzheimers Dis63, 1337–1346.
47.
DodiyaHB, KuntzT, ShaikSM, BaufeldC, LeibowitzJ, ZhangX, GottelN, ZhangX, ButovskyO, GilbertJA, SisodiaSS (2019) Sex-specific effects of microbiome perturbations on cerebral Ab amyloidosis and microglia phenotypes. J Exp Med216, 1542–1560.
48.
ReevesPG, NielsenFH, FaheyGCJr (1993) Ain-93 purified diets for laboratory rodents - final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the Ain-76a rodent diet. J Nutr123, 1939–1951.
49.
MillerBH, TakahashiJS (2014) Central circadian control of female reproductive function. Front Endocrinol (Lausanne)4, 195.
50.
WalfAA, FryeCA (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc2, 322–328.
DeaconRM, RawlinsJN (2006) T-maze alternation in the rodent. Nat Protoc1, 7–12.
54.
GerlaiR (1998) A new continuous alternation task in T-maze detects hippocampal dysfuncion in mice. A strain comparison and lesion study. Behav Brain Res95, 91–101.
55.
DavisKE, BurnettK, GiggJ (2017) Water and T-maze protocols are equally efficient methods to assess spatial memory in 3xTg Alzheimer’s disease mice. Behav Brain Res331, 54–66.
56.
SyedaT, Sanchez-TapiaM, Pinedo-VargasL, GranadosO, Cuervo-ZanattaD, Rojas-SantiagoE, Díaz-CintraS, TorresN, Perez-CruzC (2018) Bioactive food abates metabolic and synaptic alterations by modulation of the brain-gut axis in a mouse model of Alzheimer’s disease. J Alzheimers Dis66, 1657–1682.
57.
MoojenVK, Damiani-NevesM, BavarescoDV, PescadorBB, ComimCM, QuevedoJ, BoeckCR (2012) NMDA preconditioning prevents object recognition memory impairment and increases brain viability in mice exposed to traumatic brain injury. Brain Res1466, 82–90.
58.
BirdCM (2017) The role of the hippocampus in recognition memory. Cortex93, 155–165.
59.
MoriciJF, BekinschteinP, WeisstaubNV (2015) Medial prefrontal cortex role in recognition memory in rodents. Behav Brain Res292, 241–251.
60.
NunezJ (2008) Morris water maze experiment. J Vis Exp897, doi: 10.3791/897.
61.
SharmaS, RakoczyS, Brown-BorgH (2010) Assessment of spatial memory in mice. Life Sci87, 521–536.
MurugesanS, Ulloa-MartínezM, Martínez-RojanoH, Galván-RodríguezFM, Miranda-BritoC, RomanoMC, Piña-EscobedoA, Pizano-ZárateML, Hoyo-VadilloC, García-MenaJ (2015) Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children. Eur J Clin Microbiol Infect Dis34, 1337–1346.
64.
De BaereS, EeckhautV, SteppeM, De MaesschalckC, De BackerP, Van ImmerseelF, CroubelsS (2013) Development of a HPLC-UV method for the quantitative determination of four short-chain fatty acids and lactic acid produced by intestinal bacteria during in vitro fermentation. J Pharm Biomed Anal80, 107–115.
65.
Corona-CervantesK, García-GonzálezI, Villalobos-FloresLE, Hernández-QuirozF, Piña-EscobedoA, Hoyo-VadilloC, Rangel-CalvilloMN, García-MenaJ (2020) Human milk microbiota associated with early colonization of the neonatal gut in Mexican newborns. PeerJ8, e9205.
MosconiL, PupiA, De LeonMJ (2008) Brain glucose hypometabolims and oxidative stress in preclinical Alzheimer’s disease. Ann N Y Acad Sci1147, 180–195.
70.
MosconiL, BertiV, Guyara-QuinnC, McHughP, PetrongoloG, OsorioRS, ConnaughtyC, PupiA, VallabhajosulaS, IsaacsonRS, de LeonMJ, SwerdlowRH, BrintonRD (2017) Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery. PLoS One12, e0185926.
71.
VéghMJ, HeldringCM, KamphuisW, HijaziS, TimmermanAJ, LiKW, van NieropP, MansvelderHD, HolEM, SmitAB, van KesterenRE (2014) Reducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of Alzheimer’s disease. Acta Neuropathol Commun2, 76.
72.
Bruce-KellerAJ, GuptaS, KnightAG, BeckettTL, McMullenJM, DavisPR, MurphyMP, Van EldikLJ, St ClairD, KellerJN (2011) Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation. Neurobiol Dis44, 317–326.
73.
ChenY, FangL, ChenS, ZhouH, FanY, LinL, LiJ, XuJ, ChenY, MaY, ChenY (2020) Gut microbiome alterations precede cerebral amyloidosis and microglial pathology in a mouse model of Alzheimer’s disease. Biomed Res Int2020, 8456596.
74.
BäuerlC, ColladoMC, Diaz CuevasA, ViñaJ, Pérez MartínezG (2018) Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer’s disease during lifespan. Lett Appl Microbiol66, 464–471.
75.
HarachT, MarungruangN, DuthilleulN, CheathamV, Mc CoyKD, FrisoniG, NeherJJ, FåkF, JuckerM, LasserT, BolmontT (2017) Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci Rep7, 41802.
76.
MinterMR, ZhangC, LeoneV, RingusDL, ZhangX, Oyler-CastrilloP, MuschMW, LiaoF, WardJF, HoltzmanDM, ChangEB, TanziRE, SisodiaSS (2016) Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease. Sci Rep6, 30028.
77.
ZhangL, WangY, XiayuX, ShiC, ChenW, SongN, FuX, ZhouR, XuY, HuangL, ZhuH, HanY, QinC (2017) Altered gut microbiota in a mouse model of Alzheimer’s disease. J Alzheimers Dis60, 1241–1257.
78.
CoxLM, Abou-El-HassanH, MaghziAH, VincentiniJ, WeinerHL (2019) The sex-specific interaction of the microbiome in neurodegenerative diseases. Brain Res1724, 146385.
79.
YaoJ, IrwinRW, ZhaoL, NilsenJ, HamiltonRT, BrintonRD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer’s pathology in female mouse model of Alzheimer’s disease. Proc Natl Acad Sci U S A106, 14670–14675.
80.
YaoJ, HamiltonRT, CadenasE, BrintonRD (2010) Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence. Biochim Biophys Acta1800, 1121–1126.
81.
BrintonRD, YaoJ, YinF, MackWJ, CadenasE (2015) Perimenopause as a neurological transition state. Nat Rev Endocrinol11, 393–405.
82.
YinF, YaoJ, SanchetiH, FengT, MelcangiRC, MorganTE, FinchCE, PikeCJ, MackWJ, CadenasE, BrintonRD (2015) The perimenopausal aging transition in the female rat brain: Decline in bioenergetic systems and synaptic plasticity. Neurobiol Aging36, 2282–2295.
83.
DingF, YaoJ, RettbergJR, ChenS, BrintonRD (2013) Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer’s mouse brain: Implication for bioenergetic intervention. PLoS One8, e79977.
84.
KrychŁ, NielsenDS, HansenAK, HansenCH (2015) Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD Mice. Gut Microbes6, 101–109.
85.
Chávez-CarbajalA, Pizano-ZárateML, Hernández-QuirozF, Ortiz-LunaGF, Morales-HernándezRM, De Sales-MillánA, Hernández-TrejoM, García-ViteA, Beltrán-LagunesL, Hoyo-VadilloC, García-MenaJ (2020) Characterization of the gut microbiota of individuals at different T2D stages reveals a complex relationship with the host. Microorganisms8, 94.
86.
BaothmanOA, ZamzamiMA, TaherI, AbubakerJ, Abu-farhaM (2016) The role of gut microbiota in the development of obesity and diabetes. Lipids Health Dis15, 108.
87.
CoxLM, SchaferMJ, SohnJ, VincentiniJ, WeinerHL, GinsbergSD, BlaserMJ (2019) Calorie restriction slows age-related microbiota changes in an Alzheimer’s disease model in female mice. Sci Rep9, 17904.
88.
BerryD, KuzykO, RauchI, HeiderS, SchwabC, HainzlE, DeckerT, MüllerM, StroblB, SchleperC, UrichT, WagnerM, KennerL, LoyA (2015) Intestinal microbiota signatures associated with inflammation history in mice experiencing recurring colitis. Front Microbiol6, 1408.
89.
TeuberM (1985) The genus Lactococcus. The Genera of Lactic Acid Bacteria. The Lactic Acid Bacteria, Wood BJB, Holzapfel WH, eds. Springer, Boston, MA, pp. 173–234.
90.
SheedyJ, WettenhallR, ScanlonD, GooleyP, LewisD, McGregorN, StapletonD, ButtH, DE MeirleierKL (2009) Increased D-Lactic acid intestinal bacteria in patients with chronic fatigue syndrome. In Vivo23, 621–628.
91.
BerchtoldNC, CribbsDH, ColemanPD, RogersJ, HeadE, KimR, BeachT, MillerC, TroncosoJ, TrojanowskiJQ, ZielkeHR, CotmanCW (2008) Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A105, 15605–15610.
FloresR, ShiJ, FuhrmanB, XuX, VeenstraT, GailM, GajerP, RavelJ, GoedertJJ (2012) Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: A cross-sectional study. J Transl Med10, 253.
94.
HuangR, LiT, NiJ, BaiX, GaoY, LiY, ZhangP, GongY (2018) Different sex-based responses of gut microbiota during the development of hepatocellular carcinoma in liver-specific Tsc1-knockout mice. Front Microbiol9, 1008.
95.
CrostEH, TailfordLE, Le GallG, FonsM, HenrissatB, JugeN (2013) Utilisation of mucin glycans by the human gut symbiont ruminococcus gnavus is strain-dependent. PLoS One8, e76341.
96.
LeclercqS, MatamorosS, CaniPD, NeyrinckAM, JamarF, StärkelP, WindeyK, TremaroliV, BäckhedF, VerbekeK, de TimaryP, DelzenneNM (2014) Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A111, E4485–E4493.
97.
ChenJ, ChiaN, KalariKR, YaoJZ, NovotnaM, Paz SoldanMM, LuckeyDH, MariettaE V, JeraldoPR, ChenX, WeinshenkerBG, RodriguezM, KantarciOH, NelsonH, MurrayJA, MangalamAK (2016) Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep6, 28484.
98.
JavurekAB, SureshD, SpollenWG, HartML, HansenSA, EllersieckMR, BivensNJ, GivanSA, UpendranA, KannanR, RosenfeldCS (2017) Gut dysbiosis and neurobehavioral alterations in rats exposed to silver nanoparticles. Sci Rep7, 2822.
99.
SunJ, LingZ, WangF, ChenW, LiH, JinJ, ZhangH, PangM, YuJ, LiuJ (2016) Clostridium butyricum pretreatment attenuates cerebral ischemia/reperfusion injury in mice via anti-oxidation and anti-apoptosis. Neurosci Lett613, 30–35.
100.
PisaD, AlonsoR, Fernández-FernándezAM, RábanoA, CarrascoL (2017) Polymicrobial infections in brain tissue from Alzheimer’s disease patients. Sci Rep7, 5559.
101.
FigueiraJ, JonssonP, Nordin AdolfssonA, AdolfssonR, NybergL, ÖhmanA (2016) NMR analysis of the human saliva metabolome distinguishes dementia patients from matched controls. Mol Biosyst12, 2562–2571.
102.
YilmazA, GeddesT, HanB, Bahado-SinghRO, WilsonGD, ImamK, MaddensM, GrahamSF (2017) Diagnostic biomarkers of Alzheimer’s disease as identified in saliva using 1H NMR-based metabolomics. J Alzheimers Dis58, 355–359.
103.
LeBlancJG, ChainF, MartínR, Bermúdez-HumaránLG, CourauS, LangellaP (2017) Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb Cell Fact16, 79.
104.
OngL, ShahNP (2008) Influence of probiotic Lactobacillus acidophilus and L. helveticus on proteolysis, organic acid profiles, and ACE-inhibitory activity of cheddar cheeses ripened at 4, 8, and 12°C. J Food Sci73, M111–M120.
105.
ZhangC, BrandtMJ, SchwabC, GänzleMG (2010) Propionic acid production by cofermentation of Lactobacillus buchneri and Lactobacillus diolivorans in sourdough. Food Microbiol27, 390–395.
106.
XinY, DilingC, JianY, TingL, GuoyanH, HualunL, XiaocuiT, GuoxiaoL, OuS, ChaoqunZ, JunZ, YizhenX (2018) Effects of oligosaccharides from morinda officinalis on gut microbiota and metabolome of APP/PS1 transgenic mice. Front Neurol9, 412.
107.
BostanciklioğluM (2019) The role of gut microbiota in pathogenesis of Alzheimer’s disease. J Appl Microbiol127, 954–967.
108.
HeY, LiB, SunD, ChenS (2020) Gut microbiota: Implications in Alzheimer’s disease. J Clin Med9, 2042.
SheridM, SamoS, SulaimanS, HuseinH, SifuentesH, SridharS (2016) Liver abscess and bacteremia caused by lactobacillus: Role of probiotics? Case report and review of the literature. BMC Gastroenterol16, 138.
111.
WallisA, ButtH, BallM, LewisDP, BruckD (2016) Support for the microgenderome: Associations in a human clinical population. Sci Rep6, 19171.
112.
GophnaU, KonikoffT, NielsenH (2017) Oscillospira and related bacteria - from metagenomic species to metabolic features. Environ Microbiol19, 835–841.
113.
HerrmannE, YoungW, RosendaleD, Reichert-GrimmV, RiedelCU, ConradR, EgertM (2017) RNA-based stable isotope probing suggests Allobaculum spp. as particularly active glucose assimilators in a complex murine microbiota cultured in vitro. Biomed Res Int2017, 1829685.
114.
LiuC, LiJ, ZhangY, PhilipA, ShiE, ChiX, MengJ (2015) Influence of glucose fermentation on CO2 assimilation to acetate in homoacetogen Blautia coccoides GA-1. J Ind Microbiol Biotechnol42, 1217–1224.
115.
VitalM, KarchA, PieperDH (2017) Colonic butyrate-producing communities in humans: An overview using omics data. mSystems2, e00130–17.
116.
WatersJL, LeyRE (2019) The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health. BMC Biol17, 83.
117.
ZhengY, KahntJ, KwonIH, MackieRI, ThauerRK (2014) Hydrogen formation and its regulation in Ruminococcus albus: Involvement of an electron-bifurcating [FeFe]-hydrogenase, of a non-electron-bifurcating [FeFe]-hydro-genase, and of a putative hydrogen-sensing [FeFe]-hydro-genase. J Bacteriol196, 3840–3852.
118.
MacFabeDF (2015) Enteric short-chain fatty acids: Microbial messengers of metabolism, mitochondria, and mind: Implications in autism spectrum disorders. Microb Ecol Health Dis26, 28177.
119.
ShultzSR, AzizNAB, YangL, SunM, MacFabeDF, O’BrienTJ (2015) Intracerebroventricular injection of propionic acid, an enteric metabolite implicated in autism, induces social abnormalities that do not differ between seizure-prone (FAST) and seizure-resistant (SLOW) rats. Behav Brain Res278, 542–548.
120.
MacFabeDF, CainDP, Rodriguez-CapoteK, FranklinAE, HoffmanJE, BoonF, TaylorAR, KavaliersM, OssenkoppKP (2007) Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res176, 149–169.
121.
MacFabeDF, CainNE, BoonF, OssenkoppKP, CainDP (2011) Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder. Behav Brain Res217, 47–54.
122.
GovindarajanN, Agis-BalboaRC, WalterJ, SananbenesiF, FischerA (2011) Sodium butyrate improves memory function in an alzheimer’s disease mouse model when administered at an advanced stage of disease progression. J Alzheimers Dis26, 187–197.
123.
HuuskonenJ, SuuronenT, NuutinenT, KyrylenkoS, SalminenA (2004) Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids. Br J Pharmacol141, 874–80.
124.
KanskiR, SneeboerMA, van BodegravenEJ, SluijsJA, KropffW, VermuntMW, CreyghtonMP, De FilippisL, VescoviA, AronicaE, van TijnP, van StrienME, HolEM (2014) Histone acetylation in astrocytes suppresses GFAP and stimulates a reorganization of the intermediate filament network. J Cell Sci127, 4368–4380.
125.
van der VelpenV, TeavT, Gallart-AyalaH, MehlF, KonzI, ClarkC, OikonomidiA, PeyratoutG, HenryH, DelorenziM, IvanisevicJ, PoppJ (2019) Systemic and central nervous system metabolic alterations in Alzheimer’s disease. Alzheimers Res Ther11, 93.
126.
GulajE, PawlakK, BienB, PawlakD (2010) Kynurenine and its metabolites in Alzheimer’s disease patients. Adv Med Sci55, 204–211.
